Our Top 5 Podcast Episodes of 2024

1. Implementing Sustainable Business Practices

Raphael Chin Fo Sieeuw, DHL’s VP of life sciences and healthcare, Americas, uncovers:

• How his plethora of experience successfully prepared him to perform the required duties in his current position
• The latest trends that are helping to reshape and impact the pharma supply chain
• What can be done to combat 300 million tons of plastic waste every year that the global healthcare sector generates (according to the World Health Organization)
• How the industry can continue to dig itself out of the national drug shortage hole

2. Overcoming Supply Chain Challenges

Chip Davis, president and CEO of the Healthcare Distribution Alliance (HDA), a national organization that represents primary pharmaceutical distributors, discusses:

• The benefits of the Distribution Management Conference, and the value it provides for the industry
• A three-year check-in since his last chat with Pharmaceutical Commerce, including a look at how the challenges presented to distributors now differ, and how they are being addressed
• Progress that has been made toward full connectivity since the FDA announced a “stabilization period” to finalize implementation of the DSCSA before November 2024, along with some of the most significant issues for trading partners
• Some of the root causes of drug shortages, and how distributors are work to mitigate them
• Key initiatives and plans that the HDA is focused on for the second half of 2024, and how these will shape the future of the pharmaceutical supply chain

3. The Capabilities of a 3PL Provider

Chris Williams, International Managing Director of Alloga Europe and ICS, discusses:

• What’s needed to support advanced therapy medicinal products from a temperature standpoint
• The current state of third-party logistics (3PLs) in Europe and what areas need to improve
• How expectations of pharma companies have changed in terms of what they expect a 3PL partner to provide
• How Alloga’s new facilities in Spain and the Netherlands fit within the company’s strategy
• What he believes 3PLs can do to support supply chains more efficiently

4. Mitigating Drug Shortages

Allen Jacques, a life sciences industry thought leader at Kinaxis, dives into:

• What he sees as limitations of current government efforts when it comes to boosting domestic production of essential medicines, and why they aren’t sufficient
• How and why drug shortages occur
• The challenges that generic drug manufacturers are facing today
• Why more resilient and transparent supply chains are necessary in the pharmaceutical industry, and how these can help mitigate shortage issues

5. The Impact of RFID: Enhancing Medication Management

Rob Sobie, chief product officer of Intelliguard, a provider of hospital medication management and data intelligence solutions, discusses:

• The key challenges that hospitals are currently facing
• Why he believes that the drug supply chain is failing
• Successes surrounding the implementation of RFID technology
• A high-level overview of the Drug Supply Chain Security Act, along with his thoughts on the latest exemptions that were recently announced by the FDA

The latest episode of The Pharmaceutical Commerce Podcast is available directly on Audioboom, Spotify, or iHeart.